We then transfected HeLa cells with a CTNNB1 overexpression plasmid to establish WNT/β‐catenin‐activated cervical cancer cells and used WNT signaling pathway inhibitor iCRT‐3 to inhibit WNT signaling in SiHa cells. This evidence concerns the gene CTNNB1 and cervical carcinoma.